Market Vectors Israel ETF (ISRA) 28.40 $ISRA Is
Post# of 273319
Posted On: 09/25/2016 5:05:48 PM
Market Vectors Israel ETF (ISRA) 28.40 $ISRA
Israel ETFs Surge on Teva Megamerger Deal (revised)
Sweta Killa - ZACKS - Fri Jul 31, 3:11AM CDT
The takeover deal of Allergan by Teva has led to a surge in Israel ETFs.
IHE: 156.22 (+0.32), AGN: 243.94 (+0.51), PPH: 59.36 (-0.03), EIS: 49.12 (-0.03), ISRA: 28.40 (-0.01), MYL: 42.06 (-0.53), TEVA: 51.47 (+0.24)
Israel ETFs Surge on Teva Megamerger Deal - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Tue Jul 28, 9:50AM CDT
The takeover deal of Allergan by Teva has led to a surge in Israel ETFs.
IHE: 156.22 (+0.32), AGN: 243.94 (+0.51), PPH: 59.36 (-0.03), EIS: 49.12 (-0.03), ISRA: 28.40 (-0.01), TEVA: 51.47 (+0.24)
Teva/Mylan Deal Doesn’t Stir Pharma ETFs
ETFtrends.com - ETF Trends - Fri Apr 17, 2:00PM CDT
On a down day for U.S. stocks, even the latest rumor of a mega pharmaceuticals deal is proving ineffective in propping up exchange traded funds tracking the industry. Multiple media outlets are reporting that Israeli generic drug giant Teva...
EIS: 49.12 (-0.03), PJP: 64.35 (-0.14), ISRA: 28.40 (-0.01)
Pharma Focus Fabulous for Israel ETFs
ETFtrends.com - ETF Trends - Wed Apr 15, 11:00AM CDT
Increased mergers and acquisitions in the pharmaceuticals space has been a boon for healthcare-heavy Israel exchange traded funds. Year-to-date, the Market Vectors Israel ETF (NYSEArca: ISRA ) and the iShares MSCI Israel Capped ETF (NYSEArca: ...
EIS: 49.12 (-0.03), ISRA: 28.40 (-0.01)
Inside The Surging Israel ETFs - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Tue Apr 14, 10:10AM CDT
Israeli ETFs have been on the rise and are clearly crushing the global market.
PRGO: 97.40 (+0.28), ACWI: 59.13 (-0.41), SPY: 215.99 (-1.19), GAF: 59.34 (unch), GULF: 16.85 (-0.05), EIS: 49.12 (-0.03), ISRA: 28.40 (-0.01), TEVA: 51.47 (+0.24)
Pharma ETFs Soar on Acquisition Spree - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Mon Apr 13, 1:11PM CDT
The health care sector is cashing in on the merger and acquisition boom with the latest deal between Mylan N.V. and Perrigo Company plc.
IHE: 156.22 (+0.32), PRGO: 97.40 (+0.28), ISRA: 28.40 (-0.01), IBB: 298.18 (-1.90), XPH: 46.91 (+0.35), MYL: 42.06 (-0.53)
Pharma ETFs Boosted by Mylan’s Giant Offer for Perrigo
ETFtrends.com - ETF Trends - Wed Apr 08, 11:48AM CDT
Pharmaceuticals exchange traded funds are once again at the epicenter of the healthcare mergers and acquisitions as generic drugmaker Mylan (NYSE: MYL) has offered to acquire Israeli rival Perrigo (NYSE: PRGO) for $205 per share, or $28.86 billion. ...
IHE: 156.22 (+0.32), PPH: 59.36 (-0.03), PJP: 64.35 (-0.14), ISRA: 28.40 (-0.01), IBB: 298.18 (-1.90)
Healthcare Exposure Lifts Some International ETFs
ETFtrends.com - ETF Trends - Thu Apr 02, 6:30AM CDT
The Health Care Select Sector SPDR (NYSEArca: XLV ) was the best of the nine sector SPDR exchange traded funds in the first quarter, rising 6.3% while easily topping the 4.8% returned by the second best SPDR, the Consumer Discretionary Select...
EIS: 49.12 (-0.03), ISRA: 28.40 (-0.01), EDEN: 56.37 (-0.36)
Prowling Teva Could Boost Some Pharma ETFs
ETFtrends.com - ETF Trends - Mon Mar 30, 7:00AM CDT
Teva Pharmaceuticals (NasdaqGS: TEVA), the largest publicly traded Israeli company, could join the already hot healthcare mergers and acquisitions race and that could prove meaningful for some pharmaceuticals exchange traded funds. “Teva has...
PPH: 59.36 (-0.03), ISRA: 28.40 (-0.01), XPH: 46.91 (+0.35)
Israel ETFs Surge on Teva Megamerger Deal (revised)
Sweta Killa - ZACKS - Fri Jul 31, 3:11AM CDT
The takeover deal of Allergan by Teva has led to a surge in Israel ETFs.
IHE: 156.22 (+0.32), AGN: 243.94 (+0.51), PPH: 59.36 (-0.03), EIS: 49.12 (-0.03), ISRA: 28.40 (-0.01), MYL: 42.06 (-0.53), TEVA: 51.47 (+0.24)
Israel ETFs Surge on Teva Megamerger Deal - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Tue Jul 28, 9:50AM CDT
The takeover deal of Allergan by Teva has led to a surge in Israel ETFs.
IHE: 156.22 (+0.32), AGN: 243.94 (+0.51), PPH: 59.36 (-0.03), EIS: 49.12 (-0.03), ISRA: 28.40 (-0.01), TEVA: 51.47 (+0.24)
Teva/Mylan Deal Doesn’t Stir Pharma ETFs
ETFtrends.com - ETF Trends - Fri Apr 17, 2:00PM CDT
On a down day for U.S. stocks, even the latest rumor of a mega pharmaceuticals deal is proving ineffective in propping up exchange traded funds tracking the industry. Multiple media outlets are reporting that Israeli generic drug giant Teva...
EIS: 49.12 (-0.03), PJP: 64.35 (-0.14), ISRA: 28.40 (-0.01)
Pharma Focus Fabulous for Israel ETFs
ETFtrends.com - ETF Trends - Wed Apr 15, 11:00AM CDT
Increased mergers and acquisitions in the pharmaceuticals space has been a boon for healthcare-heavy Israel exchange traded funds. Year-to-date, the Market Vectors Israel ETF (NYSEArca: ISRA ) and the iShares MSCI Israel Capped ETF (NYSEArca: ...
EIS: 49.12 (-0.03), ISRA: 28.40 (-0.01)
Inside The Surging Israel ETFs - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Tue Apr 14, 10:10AM CDT
Israeli ETFs have been on the rise and are clearly crushing the global market.
PRGO: 97.40 (+0.28), ACWI: 59.13 (-0.41), SPY: 215.99 (-1.19), GAF: 59.34 (unch), GULF: 16.85 (-0.05), EIS: 49.12 (-0.03), ISRA: 28.40 (-0.01), TEVA: 51.47 (+0.24)
Pharma ETFs Soar on Acquisition Spree - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Mon Apr 13, 1:11PM CDT
The health care sector is cashing in on the merger and acquisition boom with the latest deal between Mylan N.V. and Perrigo Company plc.
IHE: 156.22 (+0.32), PRGO: 97.40 (+0.28), ISRA: 28.40 (-0.01), IBB: 298.18 (-1.90), XPH: 46.91 (+0.35), MYL: 42.06 (-0.53)
Pharma ETFs Boosted by Mylan’s Giant Offer for Perrigo
ETFtrends.com - ETF Trends - Wed Apr 08, 11:48AM CDT
Pharmaceuticals exchange traded funds are once again at the epicenter of the healthcare mergers and acquisitions as generic drugmaker Mylan (NYSE: MYL) has offered to acquire Israeli rival Perrigo (NYSE: PRGO) for $205 per share, or $28.86 billion. ...
IHE: 156.22 (+0.32), PPH: 59.36 (-0.03), PJP: 64.35 (-0.14), ISRA: 28.40 (-0.01), IBB: 298.18 (-1.90)
Healthcare Exposure Lifts Some International ETFs
ETFtrends.com - ETF Trends - Thu Apr 02, 6:30AM CDT
The Health Care Select Sector SPDR (NYSEArca: XLV ) was the best of the nine sector SPDR exchange traded funds in the first quarter, rising 6.3% while easily topping the 4.8% returned by the second best SPDR, the Consumer Discretionary Select...
EIS: 49.12 (-0.03), ISRA: 28.40 (-0.01), EDEN: 56.37 (-0.36)
Prowling Teva Could Boost Some Pharma ETFs
ETFtrends.com - ETF Trends - Mon Mar 30, 7:00AM CDT
Teva Pharmaceuticals (NasdaqGS: TEVA), the largest publicly traded Israeli company, could join the already hot healthcare mergers and acquisitions race and that could prove meaningful for some pharmaceuticals exchange traded funds. “Teva has...
PPH: 59.36 (-0.03), ISRA: 28.40 (-0.01), XPH: 46.91 (+0.35)
(0)
(0)